Elevance Health reported second quarter results that exceeded internal expectations and raised its full year guidance. The company also outlined plans to exit additional underperforming Medicaid markets while focusing on expanding Medicare Advantage and Carelon health services. The shift indicates a different mix of revenue and risk over time as Elevance Health balances membership levels, medical cost trends, and investment in service capabilities tied to Carelon.
Elevance Health IncElevance Health beat Q2 expectations and raised full-year guidance.